Nymox Pharmaceutical
NYMX
#10337
Rank
A$25.51 M
Marketcap
Country
A$0.28
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.37 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$9.13 Million, an increase over its 2021 earnings that were of -A$17.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.37 Million-63.08%
2022 -A$9.13 Million-47.71%
2021 -A$17.45 Million6.61%
2020 -A$16.37 Million-10.91%
2019 -A$18.37 Million24.24%
2018 -A$14.79 Million-20.03%
2017 -A$18.49 Million2.71%
2016 -A$18.01 Million-63.86%
2015 -A$49.82 Million674.44%
2014 -A$6.44 Million-6.11%
2013 -A$6.86 Million-35.66%
2012 -A$10.65 Million-20.76%
2011 -A$13.44 Million38.33%
2010 -A$9.72 Million35.59%
2009 -A$7.17 Million11.8%
2008 -A$6.41 Million-12.94%
2007 -A$7.37 Million8.85%
2006 -A$6.77 Million36.5%
2005 -A$4.96 Million-4.4%
2004 -A$5.19 Million-14.58%
2003 -A$6.07 Million
2001 -A$4.46 Million-20.54%
2000 -A$5.61 Million21.72%
1999 -A$4.61 Million-25.56%
1998 -A$6.19 Million101.3%
1997 -A$3.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.31 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.80 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.37 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$43.51 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.92 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA